Cunjin Su

Cunjin Su

Auto-generated profile, based on publicly available information

Cunjin Su

The Second Affiliated Hospital of Soochow University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2017 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
CSCun‐Jin Su
Cun‐Jin Su
YFYu Feng
Yu Feng
TLTeng‐Teng Liu
Teng‐Teng Liu
XLXu Liu
Xu Liu
JBJun‐Jie Bao
Jun‐Jie Bao
YYYunli Yu
Yunli Yu

13 March 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
CSCun-Jin Su
Cun-Jin Su
JZJiang-Tao Zhang
Jiang-Tao Zhang
FZFeng-Lun Zhao
Feng-Lun Zhao
DXDe-Lai Xu
De-Lai Xu
Jie PanJie Pan
Jie Pan
TLTong Liu
Tong Liu
Introduction: Paclitaxel is a chemotherapy drug that is commonly used to treat cancer, but it can cause paclitaxel-induced neuropathic pain (PINP) as a side effect. Resolvin D1 (RvD1) has been shown to be effective in promoting the resolution of inflammation and chronic pain. In this study, we evaluated the effects of RvD1 on PINP and its underlying mechanisms in mice.Methods: Behavioral analysis was used to assess the establishment of the PINP mouse model and to test the effects of RvD1 or other formulations on mouse pain behavior. Quantitative real-time polymerase chain reaction analysis was employed to detect the impact of RvD1 on 12/15 Lox, FPR2, and neuroinflammation in PTX-induced DRG neurons. Western blot analysis was used to examine the effects of RvD1 on FPR2, Nrf2, and HO-1 expression in DRG induced by PTX. TUNEL staining was used to detect the apoptosis of DRG neurons induced by BMDM conditioned medium. H2DCF-DA staining was used to detect the reactive oxygen species level of DRG neurons in the presence of PTX or RvD1+PTX treated BMDMs CM.Results: Expression of 12/15-Lox was decreased in the sciatic nerve and DRG of mice with PINP, suggesting a potential involvement of RvD1 in the resolution of PINP. Intraperitoneal injection of RvD1 promoted pain resolution of PINP in mice. Intrathecal injection of PTX-treated BMDMs induced mechanical pain hypersensitivity in naïve mice, while pretreatment of RvD1 in BMDMs prevented it. Macrophage infiltration increased in the DRGs of PINP mice, but it was not affected by RvD1 treatment. RvD1 increased IL-10 expression in the DRGs and macrophages, while IL-10 neutralizing antibody abolished the analgesic effect of RvD1 on PINP. The effects of RvD1 in promoting IL-10 production were also inhibited by N-formyl peptide receptor 2 (FPR2) antagonist. The primary cultured DRG neurons apoptosis increased after stimulation with condition medium of PTX-treated BMDMs, but decreased after pretreatment with RvD1 in BMDMs. Finally, Nrf2-HO1 signaling was additionally activated in DRG neurons after stimulation with condition medium of RvD1+PTX-treated BMDMs, but these effects were abolished by FPR2 blocker or IL-10 neutralizing antibody.Discussion: In conclusion, this study provides evidence that RvD1 may be a potential therapeutic strategy for the clinical treatment of PINP. RvD1/FPR2 upregulates IL-10 in macrophages under PINP condition, and then IL-10 activates the Nrf2- HO1 pathway in DRG neurons, relieve neuronal damage and PINP.

1 February 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
RGRan Guo
Ran Guo
FZFeng-Ming Zhou
Feng-Ming Zhou
CSCun-Jin Su
Cun-Jin Su
TLTeng-Teng Liu
Teng-Teng Liu
YZYan Zhou
Yan Zhou
LCLi-Hua Chen
Li-Hua Chen

1 January 2019 in Molecular Pain
Verified
Journal Article
Open access
PDF file
SCSu Cun-Jin
Su Cun-Jin
XJXu Jian-Hao
Xu Jian-Hao
LXLiu Xu
Liu Xu
ZFZhao Feng-Lun
Zhao Feng-Lun
PJPan Jie
Pan Jie
YZYu-Song Zhang
Yu-Song Zhang
Radiotherapy-related pain is a common adverse reaction with a high incidence among cancer patients undergoing radiotherapy and remarkably reduces the quality of life. However, the mechanisms of ionizing radiation-induced pain are largely unknown. In this study, mice were treated with 20 Gy X-ray to establish ionizing radiation-induced pain model. X-ray evoked a prolonged mechanical, heat, and cold allodynia in mice. Transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 were significantly upregulated in lumbar dorsal root ganglion. The mechanical and heat allodynia could be transiently reverted by intrathecal injection of transient receptor potential vanilloid 1 antagonist capsazepine and transient receptor potential ankyrin 1 antagonist HC-030031. Additionally, the phosphorylated extracellular regulated protein kinases (ERK) and Jun NH2-terminal Kinase (JNK) in pain neural pathway were induced by X-ray treatment. Our findings indicated that activation of transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1 is essential for the development of X-ray-induced allodynia. Furthermore, our findings suggest that targeting on transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 may be promising prevention strategies for X-ray-induced allodynia in clinical practice.

14 November 2022 in The International Journal of Biological Markers
Verified
Journal Article
Open access
YZYingtian Zhang
Yingtian Zhang
YCYaping Cheng
Yaping Cheng
LQLi-Qiang Qin
Li-Qiang Qin
YLYuanliang Liu
Yuanliang Liu
SHSijia Huang
Sijia Huang
YZYusong Zhang
Yusong Zhang
Objectives: Non-small cell lung cancer (NSCLC) is a leading type of lung cancer with a high mortality rate worldwide. Although many procedures for the diagnosis and prognosis assessment of lung cancer exist, they are often laborious, expensive, and invasive. This study aimed to develop an ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC–MS/MS)-based analysis method for the plasma biomarkers of NSCLC with the potential to indicate the stages and progression of this malignancy conveniently and reliably. Methods: A total of 53 patients with NSCLC in early stages (I–III) and advanced stage (IV) were classified into the early and advanced groups based on the tumor node metastasis staging system. A comprehensive metabolomic analysis of plasma from patients with NSCLC was performed via UPLC–MS/MS. Principal component analysis and partial least squares–discriminant analysis were conducted for statistical analysis. Potential biomarkers were evaluated and screened through receiver operating characteristic analyses and correlation analysis. Main differential metabolic pathways were also identified by utilizing metaboanalyst. Results: A total of 129 differential metabolites were detected in accordance with the criteria of VIP ≥ 1 and a P-value of ≤ 0.05. The receiver operating characteristic curves indicated that 11 of these metabolites have the potential to be promising markers of disease progression. Apparent correlated metabolites were also filtered out. Furthermore, the 11 most predominant metabolic pathways with alterations involved in NSCLC were identified. Conclusion: Our study focused on the plasma metabolomic changes in patients with NSCLC. These changes may be used for the prediction of the stage and progression of NSCLC. Moreover, we discussed the metabolic pathways wherein the altered metabolites were mainly enriched.

22 August 2025 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
ZWZhiqiang Wu
Zhiqiang Wu
JDJing Dai
Jing Dai
BLBo Lv
Bo Lv
CSCunjin Su
Cunjin Su
DXDelai Xu
Delai Xu